Known Medicine breaks a patient's tumour into thousands of tiny three-dimensional tumours, treats each with a different drug, and uses AI to predict which drugs will work. It has been acquired.
Known Medicine built a functional precision oncology platform: patient tumour samples are dissociated into thousands of micro-tumours in three-dimensional culture, exposed to candidate drugs and imaged, with AI models trained to translate the responses into predictions of clinical benefit for drug developers. The YC directory lists the company as acquired; the acquirer is not named here because no primary source was fetched at the time of checking.
Shares Y Combinator, Functional (ex vivo) drug testing, Patient-derived organoids and the tag yc.
Shares Y Combinator, Functional (ex vivo) drug testing and the tag yc.
Shares Y Combinator, Functional (ex vivo) drug testing and the tag yc.
Shares Y Combinator and the tag yc.
Shares Y Combinator and the tag yc.
Shares Y Combinator and the tag yc.
Shares Y Combinator and the tag yc.
Shares Y Combinator and the tag yc.